Competitive Technologies, Inc.
Competitive Technologies, Inc.
- ISIN: US2045121074
- Land: .
Nachricht vom 21.09.2011 | 19:38
Competitive Technologies Announces New International Distributors for Calmare(R) Scrambler Therapy(TM) Medical Devices
Competitive Technologies, Inc.
21.09.2011 19:38
---------------------------------------------------------------------------
FAIRFIELD, Conn., 2011-09-21 19:38 CEST (GLOBE NEWSWIRE) --
Competitive Technologies, Inc. (OTCQX:CTTC) today announced that it has signed
two new international distribution agreements that have resulted in immediate
orders for Calmare(r) Scrambler Therapy(tm) medical devices. The new distributors
are Ahsan Anaesthetist Ltd., which will be responsible for sales in Ireland,
and the Mediterranean for Technology & Trading SAL Offshore (MTT- Elyssa
Holding), which will be responsible for sales in sixteen countries in the
Middle East and North Africa.
'We are pleased to see the increased utilization of the Calmare Scrambler
Therapy device internationally,' said Umberto Marangoni, CTTC's Managing
Director of International Business Development. 'We believe these agreements
and a number of others we are currently negotiating in additional countries are
a reflection of the increased worldwide interest in our non-invasive pain
therapy which is free of harmful side effects.'
About Competitive Technologies, Inc
Competitive Technologies is a global leader in developing and commercializing
innovative products and technologies. CTTC is multifaceted, providing
distribution, patent and technology transfer, sales and licensing services.
CTTC's staff is focused on the needs of customers and matching those
requirements with commercially viable products or technology solutions.
CTTC is the licensed worldwide distributor of the non-invasive Calmare(r) pain
therapy medical device, which incorporates the biophysical 'Scrambler Therapy(tm)'
technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to
treat neuropathic pain, including cancer pain. The Calmare(r) device is currently
being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea.
For more information on the device, visit www.calmarett.com. Visit CTTC's
website: www.competitivetech.net.
Statements made about our future expectations are forward-looking statements
and subject to risks and uncertainties as described in our most recent Annual
Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on
October 27, 2010, and other filings with the SEC, and are subject to change at
any time. Our actual results could differ materially from these forward-looking
statements. We undertake no obligation to update publicly any forward-looking
statement.
CONTACT: Jean Wilczynski
IR Services, LLC
(860.434.2465
info@corpirservices.com)
News Source: NASDAQ OMX
21.09.2011 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Competitive Technologies, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US2045121074
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Weitere News
-
21.09.11 19:38
Competitive Technologies Announces New Interna ... -
21.09.11 19:38
Competitive Technologies Announces New Interna ... -
18.08.11 17:31
Competitive Technologies Announces Sale of 12 ... -
18.08.11 17:31
Competitive Technologies Announces Sale of 12 ... -
15.07.11 17:39
Competitive Technologies to Sell BiCOM's Medic ...
Anleihe im Fokus
8,25% Maritim-Offshore-Anleihe
Die besicherte Maritim-Offshore-Anleihe (WKN A1MLY9 / ISIN DE000A1MLY97) mit einem Volumen von bis zu € 25 Mio. und einem Zinssatz von 8,25% kann ab dem 21. Mai 2012 gezeichnet werden.
Die Laufzeit der Anleihe beträgt 2,5 Jahre, der Kupon wird halbjährlich bezahlt.
Event im Fokus
13. MKK
13. MKK - Münchner Kapitalmarkt Konferenz
am 23. & 24. Mai 2012
Über 20 Gesellschaften aus dem Small- und Mid-Cap Bereich präsentieren sich
im SOFITEL Munich Bayerpost
GBC-Fokusbox
HELMA Eigenheimbau: Rekordwerte
Im abgelaufenen Geschäftsjahr legte HELMA Eigenheimbau AG bei der Umsatz– und Ergebnisdynamik deutlich zu und erreichte damit neue Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen 2012er fairen Unternehmenswert von 19 € je Aktie ermittelt. Unser Rating lautet „KAUFEN“.
News im Fokus
SAP AG: SAP erweitert Cloud-Geschäft mit Akquisition von Ariba
22. Mai 2012, 20:48
Der AKTIONÄR News

22. Mai 21:23 Dow unverändert - Facebook weiter unter Druck - Best Buy, General ...
22. Mai 16:37 DAX mit Rebound: BMW, BASF, Bayer, Süss Microtec, Morphosys, ...
22. Mai 16:00 Facebook: Anleger stinksauer
22. Mai 15:53 Chart-Check BASF: (Fast) wieder im Aufwärtstrend
22. Mai 14:34 Süss Microtec setzt zur Aufholjagd an
Aktuelle Research-Studie
MPH Mittelständische Pharma Holding AG
Original-Research: MPH Mittelständische Pharma Holding AG (von GBC AG): KAUFEN
22. Mai 2012